Half Year Investor Conference 2002

August 1, 2002, London

Investor News August 1, 2002
Werner Wenning on Bayer’s first-half results:
“2002 is a year of transition in which we are creating the basis for future growth”
Sales and operating result depressed by continuing economic weakness and pharmaceutical product withdrawal / Divestment proceeds should mean higher net income for the full year
Download ( PDF, 582 KB ) collect


The audio recording of this event is no longer available

Recent development and First Half 2002 results
Werner Wenning,
CEO of Bayer AG
Download ( PDF, 379 KB ) collect
Last updated: January 15, 2014 Copyright © Bayer AG